Dr Richard Baird
Academic Consultant in Breast Cancer Theraputics

MA (Cambridge University)
MBBS (Guy's & St.Thomas' Hospitals, London University)
MRCP (Royal College of Physicians)
PhD (Institute of Cancer Research, London University)

 

Clinical secretary: Charlotte Scott
For referrals: charlotte.scott@addenbrookes.nhs.uk
Tel: 01223 596105

 

Academic PA: Tina Biggs
For research: tb397@medschl.cam.ac.uk
Tel: 01223 769463

 

GMC number: 
4411523
Specialties: 
  • Cancer researcher and medical oncologist at Cambridge University Hospitals, U.K.
  • Trained at University of Cambridge and Institute of Cancer Research / Royal Marsden Hospital.
  • Specialist in the care of breast cancer patients.
  • MD with PhD in molecular pharmacology and cancer drug development.
  • Expert in the testing of novel therapeutic approaches for breast cancer patients, including:
    • Design and delivery of early phase clinical trials as principal / chief investigator.
    • Looking after patients taking part in these trials.
    • Particular research focus on development of:
      • novel targeted therapies
      • drug combinations
      • better approaches for patients with brain metastases
      • companion biomarkers to identify patients most likely to respond to treatment – including liquid biopsies / circulating tumor DNA
    • Collaboration with industry partners to plan the best clinical development strategy.
  • Since 2002 co- or Principal Investigator on >80 phase 1 / 2 clinical trials.
  • Currently Chief or co-Chief Investigator on 3 multi-centre investigator-initiated clinical trials.
  • Member of trial management group for national and international trials.
  • UK national academic lead for the Association of Cancer Physicians.

Dr. Richard Baird graduated with degrees in Social and Political Sciences (Cambridge University, 1994) and Medicine (London University, 1997). After gaining Membership of the Royal College of Physicians, he undertook a translational research fellowship in Professor Paul Workman's group at the Institute of Cancer Research before completing specialist training in Medical Oncology at the Royal Marsden Hospital in London and Surrey, UK. Dr. Baird gained further experience in running early phase clinical trials during a Senior Clinical Research Training Fellowship at the Royal Marsden Drug Development Unit.

In September 2011, he was appointed to a faculty position at the University of Cambridge, as Academic Consultant in Cancer Therapeutics, and Honorary Medical Oncologist at Addenbrooke's Hospital.

He is chair of the Association of Cancer Physicians New Consultant Group, and is the UK lead investigator on a number of early phase clinical trials.